These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 23577498)
1. Considerations in the choice and administration of agents for empiric antimicrobial therapy. Baughman RP Surg Infect (Larchmt); 2005; 6 Suppl 2():S-71-82. PubMed ID: 23577498 [TBL] [Abstract][Full Text] [Related]
2. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci. Napolitano LM Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494 [TBL] [Abstract][Full Text] [Related]
3. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients. Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S; Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817 [TBL] [Abstract][Full Text] [Related]
4. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy. Ramsamy Y; Muckart DJ; Han KS S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954 [TBL] [Abstract][Full Text] [Related]
5. Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists. Boyd N; Nailor MD Pharmacotherapy; 2011 Nov; 31(11):1073-84. PubMed ID: 22026395 [TBL] [Abstract][Full Text] [Related]
6. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [TBL] [Abstract][Full Text] [Related]
7. Emerging issues in the management of infections caused by multi-drug-resistant, gram-negative bacilli. Rice LB Surg Infect (Larchmt); 2005; 6 Suppl 2():S-37-47. PubMed ID: 23577496 [TBL] [Abstract][Full Text] [Related]
8. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
9. New antibiotic agents: problems and prospects. Weber DJ; Rutala WA Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500 [TBL] [Abstract][Full Text] [Related]
10. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683 [TBL] [Abstract][Full Text] [Related]
11. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections. Turina M; Cheadle WG Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495 [TBL] [Abstract][Full Text] [Related]
12. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246 [TBL] [Abstract][Full Text] [Related]
13. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. Paterson DL Clin Infect Dis; 2008 Sep; 47 Suppl 1():S14-20. PubMed ID: 18713045 [TBL] [Abstract][Full Text] [Related]
14. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics]. Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190 [TBL] [Abstract][Full Text] [Related]
15. Use of tigecycline in critically ill patients with serious nosocomial intra-abdominal infections. Maseda E; Denis SE; Riquelme A; Gilsanz F Rev Esp Quimioter; 2013 Mar; 26(1):56-63. PubMed ID: 23546465 [TBL] [Abstract][Full Text] [Related]
16. Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit. Guervil DJ; Chau T Crit Care Nurs Q; 2013; 36(4):345-55. PubMed ID: 24002425 [TBL] [Abstract][Full Text] [Related]
17. Management of antibiotic resistance in the intensive care unit setting. Petrosillo N; Capone A; Di Bella S; Taglietti F Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683 [TBL] [Abstract][Full Text] [Related]
18. Current guidelines for the treatment of severe pneumonia and sepsis. Bodmann KF Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (an observational study of 1633 critically ill patients). Vasudevan A; Mukhopadhyay A; Goh EY; Li J; Tambyah PA Prev Med; 2013; 57 Suppl():S70-3. PubMed ID: 23246839 [TBL] [Abstract][Full Text] [Related]